Abstract Body

Background

The global shift to  tenofovir+lamivudine+dolutegravir (TLD) has improved viral suppression in women living with HIV (WLH) in pregnancy but there are limited data on birth outcomes with TLD use. In addition, despite increases in obesity in settings where HIV is prevalent, little is known about how body composition may impact associations between HIV/TLD and birth outcomes. 

Methods

We enrolled WLH on TLD and a comparison group of HIV-negative women seeking antenatal care at primary health facilities in Cape Town. Gestational age (GA) was via research ultrasound; behavioural and demographic data were from questionnaires; anthropometry was through clinical examination. Birth outcome data abstracted from medical records, including pregnancy loss (miscarriage and stillbirth), prematurity (<37w GA), low birthweight (LBW) (<2500g) and size for GA [including small- (SGA) and large-for-GA (LGA) from Intergrowth estimates]. Logistic regression models assessed the association between HIV/TLD and birth outcomes adjusting for maternal age, BMI, alcohol use and education; results are reported as adjusted odds ratios (AOR).

Results

We followed 1908 women (804 WLH, 1104 HIV-; mean age 28y, median GA at enrollment, 14w; median BMI at enrollment, 31kg/m2 [IQR, 25-35]. Birth outcomes were known for 1869 women (98%) including 65 miscarriages (3.4%), 35 stillbirths (1.9%) and 1769 live births (1735 singletons). Overall rates of prematurity, LBW, SGA and LGA were 9.4%, 12%, 13% and 12%, respectively, and did not differ between WLH and HIV- women (Figure 1). BMI did not affect the association between HIV/TLD and any birth outcome. Independent of HIV/TLD, higher BMI was associated with reductions in prematurity, LBW and SGA. For example, compared to women with normal BMI, women with class 1 obesity (BMI 30-35) experienced decreased odds of prematurity (AOR 0.59, 95% CI 0.36-0.96), LBW (AOR 0.49, 0.31-0.77), and SGA (AOR 0.52, 95% CI 0.33-0.80); Obesity classes 2&3 (BMI >35) decreased the odds of LBW (AOR 0.57, 95% CI 0.37-0.88), and SGA (AOR 0.38, 95% CI 0.23-0.61), and increased the odds of LGA (AOR 4.51, 95% CI 2.70-7.74).

Conclusions

These results suggest few meaningful differences in birth outcomes between WLH on TLD and HIV-negative women in this setting where both HIV and obesity are prevalent, while maternal BMI appears to be the major driver of birth outcomes in this cohort.